BIOMAT Database Logo BIOMAT Database Logo

[Interleukin-33/ST2: a new signaling pathway in immunity and immunopathology]. 2012

Sladjana Pavlović, and Nemanja Zdravković, and Gordana Radosavljević, and Nebojsa Arsenijević, and Miodrag L Lukić, and Ivan Jovanović
Univerzitet u Kragujevcu, Medicinski fakultet, Centar za molekulska istrazivanja, Kragujevac, Srbija.

UI MeSH Term Description Entries
D007378 Interleukins Soluble factors which stimulate growth-related activities of leukocytes as well as other cell types. They enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli. Interleukin
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D009202 Cardiomyopathies A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS). Myocardial Disease,Myocardial Diseases,Myocardial Diseases, Primary,Myocardial Diseases, Secondary,Myocardiopathies,Primary Myocardial Disease,Cardiomyopathies, Primary,Cardiomyopathies, Secondary,Primary Myocardial Diseases,Secondary Myocardial Diseases,Cardiomyopathy,Cardiomyopathy, Primary,Cardiomyopathy, Secondary,Disease, Myocardial,Disease, Primary Myocardial,Disease, Secondary Myocardial,Diseases, Myocardial,Diseases, Primary Myocardial,Diseases, Secondary Myocardial,Myocardial Disease, Primary,Myocardial Disease, Secondary,Myocardiopathy,Primary Cardiomyopathies,Primary Cardiomyopathy,Secondary Cardiomyopathies,Secondary Cardiomyopathy,Secondary Myocardial Disease
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000067596 Interleukin-33 A member of the INTERLEUKIN-1 protein family involved in the maturation of TH2 CELLS and the activation of MAST CELLS; BASOPHILS; EOSINOPHILS and NK CELLS. It is also produced by ENDOTHELIAL CELLS; EPITHELIAL CELLS and FIBROBLASTS; where it can function as an alarmin to modulate immune and inflammatory responses to tissue damage. IL-33,IL33,Interleukin 33
D000072179 Interleukin-1 Receptor-Like 1 Protein A receptor for INTERLEUKIN-33 that is related structurally to the interleukin-1 receptor. It contains three extracellular IMMUNOGLOBULIN-LIKE DOMAIN regions and associates with INTERLEUKIN-1 RECEPTOR ACCESSORY PROTEIN upon binding IL-33 to initiate signaling. It may function in the response of HELPER T CELLS to INFLAMMATION. IL1RL1 Protein,Interleukin 1 Receptor-Related Protein,Interleukin-33 Receptor,Interleukin 1 Receptor Like 1 Protein,Interleukin 1 Receptor Related Protein,Interleukin 33 Receptor,Receptor, Interleukin-33
D001161 Arteriosclerosis Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries. Arterioscleroses
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas
D012772 Shock, Septic Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status. Endotoxin Shock,Septic Shock,Shock, Endotoxic,Shock, Toxic,Toxic Shock,Toxic Shock Syndrome,Endotoxin Shocks,Shock Syndrome, Toxic,Shock, Endotoxin,Shocks, Endotoxin,Toxic Shock Syndromes

Related Publications

Sladjana Pavlović, and Nemanja Zdravković, and Gordana Radosavljević, and Nebojsa Arsenijević, and Miodrag L Lukić, and Ivan Jovanović
Interleukin-33 and ST2 Signaling in Tumor Microenvironment.
January 2019, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research,
Sladjana Pavlović, and Nemanja Zdravković, and Gordana Radosavljević, and Nebojsa Arsenijević, and Miodrag L Lukić, and Ivan Jovanović
IL-33/ST2 axis in inflammation and immunopathology.
April 2012, Immunologic research,
Sladjana Pavlović, and Nemanja Zdravković, and Gordana Radosavljević, and Nebojsa Arsenijević, and Miodrag L Lukić, and Ivan Jovanović
Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation.
September 2007, The Journal of biological chemistry,
Sladjana Pavlović, and Nemanja Zdravković, and Gordana Radosavljević, and Nebojsa Arsenijević, and Miodrag L Lukić, and Ivan Jovanović
[Advances of IL-33/ST2 signaling pathway in allergic rhinitis].
June 2020, Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery,
Sladjana Pavlović, and Nemanja Zdravković, and Gordana Radosavljević, and Nebojsa Arsenijević, and Miodrag L Lukić, and Ivan Jovanović
Dysregulated Interleukin -33/ST2 Pathway Perpetuates Chronic Inflammation in Hashimoto's Thyroiditis.
January 2019, Endocrine, metabolic & immune disorders drug targets,
Sladjana Pavlović, and Nemanja Zdravković, and Gordana Radosavljević, and Nebojsa Arsenijević, and Miodrag L Lukić, and Ivan Jovanović
A novel interleukin 33/ST2 signaling regulates inflammatory response in human corneal epithelium.
January 2013, PloS one,
Sladjana Pavlović, and Nemanja Zdravković, and Gordana Radosavljević, and Nebojsa Arsenijević, and Miodrag L Lukić, and Ivan Jovanović
The IL-33/ST2 pathway--A new therapeutic target in cardiovascular disease.
August 2011, Pharmacology & therapeutics,
Sladjana Pavlović, and Nemanja Zdravković, and Gordana Radosavljević, and Nebojsa Arsenijević, and Miodrag L Lukić, and Ivan Jovanović
IL-33/ST2 signaling pathway and Alzheimer's disease: A systematic review and meta-analysis.
July 2023, Clinical neurology and neurosurgery,
Sladjana Pavlović, and Nemanja Zdravković, and Gordana Radosavljević, and Nebojsa Arsenijević, and Miodrag L Lukić, and Ivan Jovanović
Role of interleukin 33 in human immunopathology.
January 2010, Annals of the rheumatic diseases,
Sladjana Pavlović, and Nemanja Zdravković, and Gordana Radosavljević, and Nebojsa Arsenijević, and Miodrag L Lukić, and Ivan Jovanović
An interleukin-33/ST2 signaling deficiency reduces overt pain-like behaviors in mice.
July 2013, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
Copied contents to your clipboard!